Vimarsana
Biggest News Aggregation in the World

Page 6 - Genetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetics Inc Today - Breaking & Trending Today

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing - Vimarsana News

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight testSALT LAKE CITY, April 09, 2024 -- Myriad Genetics, Inc. , a leader in genetic testing and...

Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Bought by China Universal Asset Management Co. Ltd. - Vimarsana News

Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Bought by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. raised its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 388.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 10,253 shares of the company’s stock after buying an additional 8,152 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Myriad Genetics were worth […]

Companion Diagnostics Market Worth $13.6 billion - Vimarsana News

Companion Diagnostics Market Worth $13.6 billion

/PRNewswire/ -- Companion Diagnostics Market in terms of revenue was estimated to be worth $7.5 billion in 2024 and is poised to reach $13.6 billion by 2029,...

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development - Vimarsana News

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine DevelopmentThe companies will leverage their combined experience in the development of conjugate vaccines for their clients Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine developmentIntravac...

Myriad Genetics (NASDAQ:MYGN) Releases Earnings Results, Beats Expectations By $0.03 EPS - Vimarsana News

Myriad Genetics (NASDAQ:MYGN) Releases Earnings Results, Beats Expectations By $0.03 EPS

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.03, Briefing.com reports. The business had revenue of $196.60 million for the quarter, compared to analysts’ expectations of $194.80 million. Myriad Genetics had […]